Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-022026
Filing Date
2009-09-30
Accepted
2009-09-30 15:43:01
Documents
1
Period of Report
2009-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4479
  Complete submission text file 0001140361-09-022026.txt   6611
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1101 BRICKELL AVE #701 S MIAMI FL 33131
Business Address
SCHABER CHRISTOPHER J (Reporting) CIK: 0001068029 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091095573